[144] Axos Financial, Inc. SEC Filing
Form 144 notice summary: This filing notifies a proposed sale of 620 shares of the issuer's common stock through Morgan Stanley Smith Barney LLC on 09/03/2025. The shares were acquired as restricted stock on 08/01/2021 from the issuer and carry an aggregate market value of $56,110.00. The record shows 4,380 shares were sold on 09/02/2025 by Nicholas Mosich for gross proceeds of $394,253.50. The total number of shares outstanding is listed as 56,486,144. The filer represents, by signing the notice, that they do not possess any undisclosed material adverse information about the issuer.
- None.
- None.
Insights
TL;DR: Small-volume insider sale disclosed; transaction size is modest relative to shares outstanding and likely neutral for valuation.
The filing documents a proposed sale of 620 restricted shares acquired in 2021 and an immediate prior sale of 4,380 shares. Compared with the stated 56,486,144 shares outstanding, these transactions represent a de minimis portion of the float. The details include broker (Morgan Stanley Smith Barney LLC), dates of sale, and gross proceeds for the prior sale ($394,253.50), which provide transparency about insider liquidity. Absent additional context about timing, intent, or a larger pattern of disposals, the direct market impact appears limited. This is a routine disclosure under Rule 144.
TL;DR: Proper Rule 144 disclosure completed; no disclosed material adverse information and signature language included.
The form indicates compliance with Rule 144 reporting requirements: description of the securities, acquisition date (08/01/2021), nature of acquisition (Restricted Stock), broker information, and recent prior sale data. The filing includes the standard attestation that the seller is unaware of undisclosed material adverse information. From a governance perspective, the filing meets procedural expectations. There is no disclosure here of trading-plan adoption dates or other governance actions that would materially change assessment.